New study brings opioid addiction treatment to community centers

NCT ID NCT06416020

Not yet recruiting Disease control Sponsor: Howard University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether offering medication for opioid use disorder (buprenorphine) in community settings—like churches or social service centers—via telemedicine, plus one-on-one coaching, helps people stay in treatment longer than standard clinic care. About 400 participants will be randomly assigned to one of two groups and followed for 24 weeks. The goal is to improve retention and reduce opioid use in high-risk urban neighborhoods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: buprenorphine
What this could lead to: If successful, this approach could make it easier for people with opioid use disorder to stay in treatment and reduce overdose risk.
What could go wrong: This is an early-stage behavioral study; results may not show a clear benefit, and telemedicine or community support may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

Contacts and locations

Locations

Howard University

Washington D.C., District of Columbia, 20059, United States
University of Illinois- Chicago

Chicago, Illinois, 60608, United States
University of Maryland

Baltimore, Maryland, 21223, United States
University of Miami

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.